State Ledger
Company profile

Benitec Biopharma Inc. CIK 1808898

Ticker
BNTC (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Hayward, CA 94545
Fiscal year end
2026 (FY)
Market Data
Close
$8.87
Change
+$0.11
Change %
1.20%
Volume
4,204

BNTC · trading date Oct 9, 2026 · previous close $8.76 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$45.55M
Total assets
$182.62M
Total liabilities
$5.61M
Stockholders' equity
$177.01M
Cash & equivalents
$179.97M
Operating income
-$51.19M
Operating cash flow
-$16.52M
Capital expenditures
$105.0K

Fiscal year 2026, via 10-K filed 2026-09-14. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$16.62M
Free cash flow margin
—
Liabilities / assets
3.1%
Equity / assets
96.9%
CapEx / revenue
—
Operating cash flow / net income
0.36×

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 — -$45.55M $182.62M $5.61M $177.01M
2025 — -$37.92M $99.59M $2.30M $97.30M
2024 — -$21.75M $52.21M $4.96M $47.25M
2023 — -$19.56M $4.46M $4.26M $202.0K
2022 — -$18.21M $5.97M $3.09M $2.88M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form S-3
2026-09-14
Financials filed via
Form 10-K
filed 2026-09-14

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Hayward, CA 94545
3940 TRUST WAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies